Allison C. Hoffman Sells 3,496 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total transaction of $103,901.12. Following the sale, the general counsel now owns 142,630 shares of the company’s stock, valued at approximately $4,238,963.60. The trade was a 2.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Phreesia Stock Performance

NYSE:PHR opened at $28.20 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The firm has a market cap of $1.64 billion, a PE ratio of -19.18 and a beta of 0.96. The business has a 50 day moving average price of $27.29 and a 200-day moving average price of $23.84.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter in the prior year, the company posted ($0.58) EPS. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. Equities research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Trading of Phreesia

Several large investors have recently modified their holdings of PHR. Johnson Financial Group Inc. raised its position in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. R Squared Ltd bought a new stake in shares of Phreesia in the 4th quarter worth approximately $30,000. International Assets Investment Management LLC increased its stake in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares during the period. BankPlus Trust Department bought a new position in shares of Phreesia during the fourth quarter valued at approximately $34,000. Finally, Quarry LP raised its holdings in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after acquiring an additional 1,923 shares in the last quarter. 92.10% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PHR has been the topic of several research reports. JMP Securities restated a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Citigroup raised their price target on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Piper Sandler reiterated an “overweight” rating and set a $33.00 price objective (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Needham & Company LLC restated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. Finally, Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.